Matthew E Gegg (Matthew Gegg, M E Gegg)

Years Active: 2017-2023
Publications (10 Years): 5

UCL Institute of Neurology, University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

UCL Institute of Neurology, University College London

United Kingdom

PHD :: Neurochemistry

Publications

Michael J Hurley, Elisa Menozzi, Sofia Koletsi, Rachel Bates, Matthew E Gegg, Kai-Yin Chau, Hervé M Blottière, Jane Macnaughtan, Anthony H V Schapira
α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study. Brain communications 5 (6) (2023)
Shi Yu Yang, Jan-Willem Taanman, Matthew E Gegg, Anthony H V Schapira
Ambroxol reverses tau and α-synuclein accumulation in a cholinergic N370S GBA1 mutation model. Human molecular genetics 31 (14) (2022)
Laura J Smith, Magdalena M Bolsinger, Kai-Yin Chau, Matthew E Gegg, Anthony H V Schapira
The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines. Human molecular genetics (2022)
J Magalhaes, Matthew E Gegg, A Migdalska-Richards, Anthony H V Schapira
Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Scientific reports 8 (1) (2018)
Kerri J Kinghorn, Sebastian Grönke, Jorge Iván Castillo-Quan, Nathaniel S Woodling, Li Li, Ernestas Sirka, Matthew E Gegg, Kevin Mills, John Hardy, Ivana Bjedov, Linda Partridge
A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin. The Journal of neuroscience : the official journal of the Society for Neuroscience 36 (46) (2017)

Matthew E Gegg.css-eqlu8i{font-size:small;padding-left:4px;} (Matthew Gegg, M E Gegg)